Hypertension and Renal Organ Damage

This book guides readers through a wide spectrum of clinical presentations in patients with arterial hypertension and different degrees of renal impairment, ranging from asymptomatic urine abnormalities to end stage renal disease. On the basis of six case studies, the author reviews and discusses current guidelines and recommendations aimed at optimizing the diagnostic and therapeutic approach both to renal and cardiovascular risk in commonly encountered real-world clinical scenarios including challenging cases of diabetic kidney disease, ischemic nephropathy and resistant hypertension. It also explores anti-hypertensive drug combinations, including single or multiple RAAS-I, lipid lowering and antiplatelet drugs, as well as the appropriate use of glucose lowering drugs in the context of chronic kidney disease. This handy and practical book provides physicians in the area of general and internal medicine, as well as specialists in the cardiovascular, metabolic and renal fields valuable insights into optimal therapeutic targets for blood pressure and glucose control in renal patients.

Roberto Pontremoli is Associate Professor of Medicine at the Department of Internal Medicine, University of Genoa Medical School, Italy. He is the chief of the Hypertension Unit at the University Medical School and San Martino Hospital in Genoa and has extensive experience as a clinical investigator in the field of renal and cardiovascular medicine. 
He is a European Society of Hypertension (ESH) specialist, a member of the directory board of the Italian Society of Hypertension and former secretary and founding member of the Italian Society of Nephro-Cardiology.
He further is an associate editor of scientific journals such as Internal and Emergency Medicine, the International Journal of Hypertension and editorial board member of the Journal of Hypertension and the Journal of Nephrology.
Prof. Pontremoli's research interests include cardio-renal interactions in hypertension, albuminuria as a cardiovascular and renal risk marker and diabetic nephropathy. He is author or co-author of over 150 PudMed indexed publications in peer-reviewed journals.